Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: Secondary analysis from the phase 3 ASPIRE study Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Multiple Myeloma

abstract

  • clinicaltrials.gov identifier: NCT01080391.

publication date

  • January 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5412871

Digital Object Identifier (DOI)

  • 10.1111/bjh.14549

PubMed ID

  • 28211560

Additional Document Info